Combined Phytosterol and Fish Oil Therapy for Lipid Lowering and Cardiovascular Health

Food Structures, Digestion and Health

Volumn , Issue , 2014, Pages 437-463

  Phang, Melinda ^a   Garg, Manohar ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

HDL cholesterol; LDL cholesterol; Lipids; Omega 3 fatty acids; Phytosterol; Statins

Indexed keywords

ALCOHOLS; CARDIOLOGY; CHOLESTEROL; DIETARY SUPPLEMENTS; DISEASES; LIPIDS; POLYUNSATURATED FATTY ACIDS;

HDL CHOLESTEROLS; LDL CHOLESTEROL; OMEGA-3-FATTY ACIDS; PHYTOSTEROL; STATINS;

FATTY ACIDS;

EID: 84936940701     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-404610-8.00016-5     Document Type: Chapter

References (147)

1. Abumweis S.S., Barake R., Jones P.J. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr. Res. 2008, 52.
2. Akiba S., Murata T., Kitatani K., Sato T. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol. Pharm. Bull. 2000, 23:1293-1297.
3. Altmann S.W., Davis H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004, 303:1201-1204.
4. Andersson S.W., Skinner J., Ellegard L., Welch A.A., Bingham S., Mulligan A., et al. Intake of dietary plant sterols is inversely related to serum cholesterol concentration in men and women in the EPIC Norfolk population: a cross-sectional study. Eur. J. Clin. Nutr. 2004, 58:1378-1385.
5. Axelrod L., Camuso J., Williams E., Kleinman K., Briones E., Schoenfeld D. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study. Diabetes Care 1994, 17:37-44.
6. Berger A., Jones P.J., Abumweis S.S. Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis. 2004, 3:5.
7. Bernard J. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia. Curr. Opin. Investig. Drugs 2008, 9:1078-1083.
8. Bhattacharyya A.K., Connor W.E. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J. Clin. Invest. 1974, 53:1033-1043.
9. Borggreve S.E., Hillege H.L., Dallinga-Thie G.M., de Jong P.E., Wolffenbuttel B.H., Grobbee D.E., et al. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. Eur. Heart J. 2007, 28:1012-1018.
10. Brown A.M., Castle J., Hebbachi A.M., Gibbons G.F. Administration of n-3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion. Arterioscler. Thromb. Vasc. Biol. 1999, 19:106-114.
11. Bruce C., Sharp D.S., Tall A.R. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J. Lipid Res. 1998, 39:1071-1078.
12. Brufau G., Canela M.A., Rafecas M. Phytosterols: physiologic and metabolic aspects related to cholesterol-lowering properties. Nutr. Res. 2008, 28:217-225.
13. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 2005, 45:581-597.
14. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757-761.
15. Calder P.C. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.) 2004, 107:1-11.
16. Carr T.P., Jesch E.D. Food components that reduce cholesterol absorption. Adv. Food Nutr. Res. 2006, 51:165-204.
17. Cerqueira M.T., Fry M.M., Connor W.E. The food and nutrient intakes of the Tarahumara Indians of Mexico. Am. J. Clin. Nutr. 1979, 32:905-915.
18. Clarke S.D. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 2004, 15:13-18.
19. Clifton P. Plant sterol and stanols-comparison and contrasts. Sterols versus stanols in cholesterol-lowering: is there a difference?. Atheroscler. Suppl. 2002, 3:5-9.
20. Clifton P.M., Mano M., Duchateau G.S., van der Knaap H.C., Trautwein E.A. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur. J. Clin. Nutr. 2008, 62:968-977.
21. Colquhoun D., Ferreira-Jardim A., Udell T., Eden B. Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health. Review of Evidence. National Heart Foundation of Australia, 1-54 2008.
22. Connor W.E. Dietary sterols: their relationship to atherosclerosis. J. Am. Diet. Assoc. 1968, 52:202-208.
23. Connor W.E. Hypolipidemic effects of dietary w-3 fatty acids in normal and hyperlipidemic humans: effectiveness and mechanisms. Health Effects of Polyunsaturated Fatty Acids in Seafoods 1986, 173. Academic Press, New York. A.P. Simopoulos, R.R. Kifer, R.E. Martin (Eds.).
24. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 2000, 86:943-949.
25. Davidson M.H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol. 2006, 98:27i-33i.
26. De Caterina R., Zampolli A. Lipids. n-3 fatty acids: antiatherosclerotic effects. Lipids 2001, 36(Suppl.):S69-S78.
27. de Jong N., Zuur A., Wolfs M.C., Wendel-Vos G.C., van Raaij J.M., Schuit A.J. Exposure and effectiveness of phytosterol/-stanol-enriched margarines. Eur. J. Clin. Nutr. 2007, 61:1407-1415.
28. Demonty I., Chan Y.M., Pelled D., Jones P.J. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am. J. Clin. Nutr. 2006, 84:1534-1542.
29. Demonty I., Ras R.T., van der Knaap H.C., Duchateau G.S., Meijer L., Zock P.L., et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J. Nutr. 2009, 139:271-284.
30. Eisenberg D. Naturally available oils contain phytosterols that affect cholesterol absorption. Curr. Atheroscler. Rep. 2003, 5:55.
31. Eisenberg S. Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system. Klin. Wochenschr. 1983, 61:119-132.
32. Ewart H.S., Cole L.K., Kralovec J., Layton H., Curtis J.M., Wright J.L., Murphy M.G. Fish oil containing phytosterol esters alters blood lipid profiles and left ventricle generation of thromboxane a(2) in adult guinea pigs. J. Nutr. 2002, 132:1149-1152.
33. Field F.J., Mathur S.N. Beta-sitosterol: esterification by intestinal acylcoenzyme A: cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. J. Lipid Res. 1983, 24:409-417.
34. Fitzgerald M.L., Mujawar Z., Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 2010, 211:361-370.
35. Fletcher B., Berra K., Ades P., Braun L.T., Burke L.E., Durstine J.L., et al. Managing abnormal blood lipids: a collaborative approach. Circulation 2005, 112:3184-3209.
36. Funatsu T., Suzuki K., Goto M., Arai Y., Kakuta H., Tanaka H., et al. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. Atherosclerosis 2001, 157:107-115.
37. Garti N., Avrahami M., Aserin A. Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. J. Colloid Interface Sci. 2006, 299:352-365.
38. Gaudette D.C., Holub B.J. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity. Lipids 1990, 25:166-169.
39. Ginsberg G.L., Toal B.F. Quantitative approach for incorporating methylmercury risks and omega-3 fatty acid benefits in developing species-specific fish consumption advice. Environ. Health Perspect. 2009, 117:267-275.
40. Goodnight S.H., Harris W.S., Connor W.E., Illingworth D.R. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982, 2:87-113.
41. Gotto A.M., Brinton E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J. Am. Coll. Cardiol. 2004, 43:717-724.
42. Grimsgaard S., Bonaa K.H., Hansen J.B., Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am. J. Clin. Nutr. 1997, 66:649-659.
43. Grundt H., Nilsen D.W. n-3 fatty acids and cardiovascular disease. Haematologica 2008, 93:807-812.
44. Grundy S.M., Denke M.A. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 1990, 31:1149-1172.
45. Gylling H., Miettinen T.A. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism 1999, 48:575-580.
46. Haikal Z., Play B., Landrier J.F., Giraud A., Ghiringhelli O., Lairon D., Jourdheuil-Rahmani D. NPC1L1 and SR-BI are involved in intestinal cholesterol absorption from small-size lipid donors. Lipids 2008, 43:401-408.
47. Harris W.S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 1989, 30(6):785-807.
48. Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
49. Harris W.S., Mozaffarian D., Rimm E., Kris-Etherton P., Rudel L.L., Appel L.J., et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009, 119:902-907.
50. Heinemann T., Axtmann G., von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur. J. Clin. Invest. 1993, 23:827-831.
51. Hendriks H.F., Brink E.J., Meijer G.W., Princen H.M., Ntanios F.Y. Safety of long-term consumption of plant sterol esters-enriched spread. Eur. J. Clin. Nutr. 2003, 57:681-692.
52. Hjerkinn E.M., Seljeflot I., Ellingsen I., Berstad P., Hjermann I., Sandvik L., Arnesen H. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am. J. Clin. Nutr. 2005, 81:583-589.
53. Hofmann A.F., Borgstroem B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. 1964, 43:247-257.
54. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J. Am. Coll. Nutr. 2001, 20:5-19.
55. Hui D.Y., Labonte E.D., Howles P.N. Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G839-G843.
56. Ikeda I., Tanabe Y., Sugano M. Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J. Nutr. Sci. Vitaminol. (Tokyo) 1989, 35:361-369.
57. Itzhaki H., Borochov A., Mayak S. Age-related changes in petal membranes from attached and detached rose flowers. Plant Physiol. 1990, 94:1233-1236.
58. Izar M.C., Tegani D.M., Kasmas S.H., Fonseca F.A. Phytosterols and phytosterolemia: gene-diet interactions. Genes Nutr. 2011, 6:17-26.
59. Jandacek R.J., Webb M.R., Mattson F.H. Effect of an aqueous phase on the solubility of cholesterol in an oil phase. J. Lipid Res. 1977, 18:203-210.
60. Jimenez-Escrig A., Santos-Hidalgo A.B., Saura-Calixto F. Common sources and estimated intake of plant sterols in the Spanish diet. J. Agric. Food Chem. 2006, 54:3462-3471.
61. Jones P.J., Demonty I., Chan Y.M., Herzog Y., Pelled D. Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects. Lipids Health Dis. 2007, 6:28.
62. Jones P.J., Raeini-Sarjaz M., Ntanios F.Y., Vanstone C.A., Feng J.Y., Parsons W.E. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J. Lipid Res. 2000, 41:697-705.
63. Jump D.B. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 2008, 19:242-247.
64. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., Demeure O. Fatty acid regulation of hepatic gene transcription. J. Nutr. 2005, 135:2503-2506.
65. Jump D.B., Botolin D., Wang Y., Xu J., Demeure O., Christian B. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem. Phys. Lipids 2008, 153:3-13.
66. Karupaiah T., Sundram K. Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. Nutr. Metab. (Lond.) 2007, 4:16.
67. Kastelein J.J., Akdim F., Stroes E.S., Zwinderman A.H., Bots M.L., Stalenhoef A.F., et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N. Engl. J. Med. 2008, 358:1431-1443.
68. Kiechl S., Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1484-1490.
69. Kinsella J.E., Lokesh B., Stone R.A. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clin. Nutr. 1990, 52:1-28.
70. Klingberg S., Ellegard L., Johansson I., Hallmans G., Weinehall L., Andersson H., Winkvist A. Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden. Am. J. Clin. Nutr. 2008, 87:993-1001.
71. Knapp H.R., Reilly I.A., Alessandrini P., FitzGerald G.A. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med. 1986, 314:937-942.
72. Kolovou G.D., Anagnostopoulou K.K., Cokkinos D.V. Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad. Med. J. 2005, 81:358-366.
73. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000, 102:2284-2299.
74. Law M.R. Plant sterol and stanol margarines and health. West. J. Med. 2000, 173:43-47.
75. Ling W.H., Jones P.J. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 1995, 57:195-206.
76. Lombardo Y.B., Chicco A.G. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem. 2006, 17:1-13.
77. Lopez-Garcia E., Schulze M.B., Manson J.E., Meigs J.B., Albert C.M., Rifai N., et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J. Nutr. 2004, 134:1806-1811.
78. Lutjohann D., Bjorkhem I., Beil U.F., von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J. Lipid Res. 1995, 36:1763-1773.
79. Madsen M.B., Jensen A.M., Schmidt E.B. The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects. Clin. Nutr. 2007, 26:792-798.
80. Mahley R.W. Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology. Circulation 1985, 72:943-948.
81. Marchioli R. [Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione]. Cardiologia 1999, 44(Suppl. 1(Pt 2)):745-746.
82. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903.
83. Marcus A.J. The eicosanoids in biology and medicine. J. Lipid Res. 1984, 25:1511-1516.
84. Marsan M.P., Warnock W., Muller I., Nakatani Y., Ourisson G., Milon A. Synthesis of deuterium-labeled plant sterols and analysis of their side-chain mobility by solid state deuterium NMR. J. Org. Chem. 1996, 61:4252-4257.
85. Matsuura E., Hughes G.R., Khamashta M.A. Oxidation of LDL and its clinical implication. Autoimmun. Rev. 2008, 7:558-566.
86. Mattson F.H., Grundy S.M., Crouse J.R. Optimizing the effect of plant sterols on cholesterol absorption in man. Am. J. Clin. Nutr. 1982, 35:697-700.
87. Mattson F.H., Volpenhein R.A., Erickson B.A. Effect of plant sterol esters on the absorption of dietary cholesterol. J. Nutr. 1977, 107:1139-1146.
88. McNamara J.R., Shah P.K., Nakajima K., Cupples L.A., Wilson P.W., Ordovas J.M., Schaefer E.J. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin. Chem. 1998, 44:1224-1232.
89. Micallef M.A., Garg M.L. The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J. Nutr. 2008, 138:1086-1090.
90. Micallef M.A., Garg M.L. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia. J. Nutr. Biochem. 2009, 20:927-939.
91. Moreau R.A., Whitaker B.D., Hicks K.B. Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Prog. Lipid Res. 2002, 41:457-500.
92. Mori T.A., Beilin L.J., Burke V., Morris J., Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 1997, 17:279-286.
93. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71:1085-1094.
94. Moruisi K.G., Oosthuizen W., Opperman A.M. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J. Am. Coll. Nutr. 2006, 25:41-48.
95. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
96. Nair P.P. Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Introduction: correlates of diet, nutrient intake, and metabolism in relation to colon cancer. Am. J. Clin. Nutr. 1984, 40(4 Suppl.):880-886.
97. NCEP Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
98. Nestel P., Cehun M., Pomeroy S., Abbey M., Weldon G. Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur. J. Clin. Nutr. 2001, 55:1084-1090.
99. Nestel P.J., Connor W.E., Reardon M.F., Connor S., Wong S., Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J. Clin. Invest. 1984, 74:82-89.
100. Noakes M., Clifton P., Ntanios F., Shrapnel W., Record I., McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am. J. Clin. Nutr. 2002, 75:79-86.
101. Noakes M., Clifton P.M., Doornbos A.M., Trautwein E.A. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur. J. Nutr. 2005, 44:214-222.
102. Normen A.L., Brants H.A., Voorrips L.E., Andersson H.A., van den Brandt P.A., Goldbohm R.A. Plant sterol intakes and colorectal cancer risk in the Netherlands Cohort Study on Diet and Cancer. Am. J. Clin. Nutr. 2001, 74:141-148.
103. Oh K., Hu F.B., Manson J.E., Stampfer M.J., Willett W.C. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am. J. Epidemiol. 2005, 161:672-679.
104. Ostlund R.E., McGill J.B., Zeng C.M., Covey D.F., Stearns J., Stenson W.F., Spilburg C.A. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E911-916.
105. Ostlund R.E., Racette S.B., Okeke A., Stenson W.F. Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am. J. Clin. Nutr. 2002, 75:1000-1004.
106. Ostlund R.E., Racette S.B., Stenson W.F. Inhibition of cholesterol absorption by phytosterol-replete wheat germ compared with phytosterol-depleted wheat germ. Am. J. Clin. Nutr. 2003, 77:1385-1389.
107. Phillips K.M., Ruggio D.M., Ashraf-Khorassani M. Phytosterol composition of nuts and seeds commonly consumed in the United States. J. Agric. Food Chem. 2005, 53:9436-9445.
108. Plana N., Nicolle C., Ferre R., Camps J., Cos R., Villoria J., Masana L. Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects. Eur. J. Nutr. 2008, 47:32-39.
109. Plat J., Mensink R.P. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J. 2002, 16:1248-1253.
110. Plat J., Mensink R.P. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur. J. Clin. Invest. 2002, 32:242-250.
111. Pollak O.J. Reduction of blood cholesterol in man. Circulation 1953, 7:702-706.
112. Prichard B.N., Smith C.C., Ling K.L., Betteridge D.J. Fish oils and cardiovascular disease. BMJ 1995, 310:819-820.
113. Prisco D., Filippini M., Francalanci I., Paniccia R., Gensini G.F., Serneri G.G. Effect of n-3 fatty acid ethyl ester supplementation on fatty acid composition of the single platelet phospholipids and on platelet functions. Metabolism 1995, 44:562-569.
114. Rideout T.C., Chan Y.M., Harding S.V., Jones P.J. Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies. Lipids Health Dis. 2009, 8:45.
115. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
116. Roshanai F., Sanders T., Howarth D., Haines A. Prostaglandin precursors in platelet phosphoglycerides following acute myocardial infarction. Thrombosis Research 1981, 24:169-173.
117. Rudkowska I., AbuMweis S.S., Nicolle C., Jones P.J. Association between non-responsiveness to plant sterol intervention and polymorphisms in cholesterol metabolism genes: a case-control study. Appl. Physiol. Nutr. Metab. 2008, 33:728-734.
118. Russell J.C., Ewart H.S., Kelly S.E., Kralovec J., Wright J.L., Dolphin P.J. Improvement of vascular dysfunction and blood lipids of insulin-resistant rats by a marine oil-based phytosterol compound. Lipids 2002, 37:147-152.
119. Ruxton C. Health benefits of omega-3 fatty acids. Nurs. Stand. 2004, 18:38-42.
120. Salen G., Ahrens E.H., Grundy S.M. Metabolism of beta-sitosterol in man. J. Clin. Invest. 1970, 49:952-967.
121. Salen G., Patel S., Batta A.K. Sitosterolemia. Cardiovasc. Drug Rev. 2002, 20:255-270.
122. Salmon J.A., Terano T. Supplementation of the diet with eicosapentaenoic acid: a possible approach to the treatment of thrombosis and inflammation. Proc. Nutr. Soc. 1985, 44:385-389.
123. Sanders T.A., Hochland M.C. A comparison of the influence on plasma lipids and platelet function of supplements of omega 3 and omega 6 polyunsaturated fatty acids. Br. J. Nutr. 1983, 50:521-529.
124. Saynor R. Effects of omega-3 fatty acids on serum lipids. Lancet 1984, 2:696-697.
125. Saynor R., Verel D., Gillott T. The effect of MaxEPA on the serum lipids, platelets, bleeding time and GTN consumption. Br. J. Clin. Pract. Suppl. 1984, 31:70-74.
126. Seo T., Blaner W.S., Deckelbaum R.J. Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr. Opin. Lipidol. 2005, 16:11-18.
127. Simopoulos A.P. Omega-3 fatty acids and cardiovascular disease: The epidemiological evidence. Environ. Health Prevent. Med. 2002, 6:203-209.
128. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomedicine and Pharmacotherapy = Biomedecine and Pharmacotherapie 2006, 60:502-507.
129. Stamler J., Wentworth D., Neaton J.D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986, 256:2823-2828.
130. Subbiah M.T., Kottke B.A., Carlo I.A. Uptake of campesterol in pigeon intestine. Biochim. Biophys. Acta 1971, 249:643-646.
131. Sudhop T., Sahin Y., Lindenthal B., Hahn C., Luers C., Berthold H.K., von Bergmann K. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion. Gut 2002, 51:860-863.
132. Tikkanen M.J. Plant sterols and stanols. Handb. Exp. Pharmacol. 2005, 170:215-230.
133. Valsta L.M., Lemstrom A., Ovaskainen M.L., Lampi A.M., Toivo J., Korhonen T., Piironen V. Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br. J. Nutr. 2004, 92:671-678.
134. von Schacky C., Weber P.C. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest. 1985, 76:2446-2450.
135. Wang H.H., Patel S.B., Carey M.C., Wang D.Q. Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hepatology 2007, 45:998-1006.
136. Wang N., Lan D., Chen W., Matsuura F., Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 2004, 101:9774-9779.
137. Wang N., Silver D.L., Thiele C., Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 2001, 276:23742-23747.
138. Weihrauch J.L., Gardner J.M. Sterol content of foods of plant origin. J. Am. Diet. Assoc. 1978, 73:39-47.
139. Weintraub M.S., Zechner R., Brown A., Eisenberg S., Breslow J.L. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J. Clin. Invest. 1988, 82:1884-1893.
140. Wensing A.G., Mensink R.P., Hornstra G. Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects. Br. J. Nutr. 1999, 82:183-191.
141. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 1998, 52:334-343.
142. Wolfs M., de Jong N., Ocke M.C., Verhagen H., Monique Verschuren W.M. Effectiveness of customary use of phytosterol/-stanol enriched margarines on blood cholesterol lowering. Food Chem. Toxicol. 2006, 44:1682-1688.
143. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Barden A., Watts G.F., Beilin L.J. Effects of purified eicosapentaenoic acid and docosahexenoic acid on platelet, fibrinolytic and vascular function in hypersensitive type 2 diabetic patients. Antherosclerosis 2003, 166:85-93.
144. Yamanashi Y., Takada T., Suzuki H. Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol uptake in CaCo-2 cells. J. Pharmacol. Exp. Ther. 2007, 320:559-564.
145. Yaqoob P. Fatty acids and the immune system: from basic science to clinical applications. Proc. Nutr. Soc. 2004, 63:89-104.
146. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
147. Zampelas A., Panagiotakos D.B., Pitsavos C., Das U.N., Chrysohoou C., Skoumas Y., Stefanadis C. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J. Am. Coll. Cardiol. 2005, 46:120-124.